Guru Ownership Trend
Guru Analysis for Halozyme Therapeutics, Inc. (HALO)
Halozyme Therapeutics, Inc. (HALO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $375.32 M.
Top institutional holders include Cliff Asness and Joel Greenblatt.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $43.23 M net outflow during the quarter.
Recent activity highlights Manning & Napier Group who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 34.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Halozyme Therapeutics, Inc. (HALO)
Major holders include Cliff Asness ($61.49 M), Joel Greenblatt ($57.86 M), Renaissance Technologies (RenTech) ($37.54 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 2.99 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $43.23 M, with 2 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 6 managers trimmed their positions, while 0 fully exited HALO. The total reported sell value was $44.33 M.
Yes, 1 managers opened new positions in HALO, and 1 increased their existing holdings. The total reported buy value was $1.11 M.
